Outlook Therapeutics Inc (OTLK)
6.04
-0.01
(-0.17%)
USD |
NASDAQ |
Nov 04, 16:00
6.34
+0.30
(+4.97%)
After-Hours: 07:44
Outlook Therapeutics Shareholders Equity (Quarterly): -83.67M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -83.67M |
| March 31, 2024 | -134.24M |
| December 31, 2023 | -24.34M |
| September 30, 2023 | -14.44M |
| June 30, 2023 | -5.503M |
| March 31, 2023 | 10.49M |
| December 31, 2022 | 15.76M |
| September 30, 2022 | 8.737M |
| June 30, 2022 | 20.08M |
| March 31, 2022 | 35.96M |
| December 31, 2021 | 48.82M |
| September 30, 2021 | 4.607M |
| June 30, 2021 | 12.75M |
| March 31, 2021 | 20.65M |
| December 31, 2020 | -10.48M |
| September 30, 2020 | 2.826M |
| June 30, 2020 | 10.97M |
| March 31, 2020 | -20.52M |
| Date | Value |
|---|---|
| December 31, 2019 | -25.41M |
| September 30, 2019 | -10.77M |
| June 30, 2019 | -1.358M |
| March 31, 2019 | -23.05M |
| December 31, 2018 | -21.47M |
| September 30, 2018 | -20.81M |
| June 30, 2018 | -9.265M |
| March 31, 2018 | -15.27M |
| December 31, 2017 | -7.898M |
| September 30, 2017 | -30.73M |
| June 30, 2017 | -28.94M |
| March 31, 2017 | -26.85M |
| December 31, 2016 | -21.83M |
| September 30, 2016 | -5.173M |
| June 30, 2016 | 1.563M |
| March 31, 2016 | -20.47M |
| December 31, 2015 | -12.02M |
| September 30, 2015 | -28.60M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-134.24M
Minimum
Mar 2024
48.82M
Maximum
Dec 2021
-6.682M
Average
4.607M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Imunon Inc | 3.741M |
| Cormedix Inc | 58.71M |
| Brainstorm Cell Therapeutics Inc | -3.527M |
| Predictive Oncology Inc | 4.094M |
| NovaBay Pharmaceuticals Inc | -0.617M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 47.09M |
| Total Liabilities (Quarterly) | 130.77M |